RA
Rafarma Pharmaceuticals, Inc.
RAFA · OTC
$0.02 -7.69% (-$0.00)
1M +26.25%
Market Cap $2.28M
P/E Ratio 6.54x
Div. Yield -
ROE 3.34%
Bulios Fair Price
$0.04
66.7% upside
Trenutna cena
$0.024
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica RAFA trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
100 /100
Cheap P/E 6.54x
EV/EBITDA 4.59x
P/S 0.25x
Growth
0 /100
Declining EPS growth 58.63%
Rev. growth 47.74%
Book val. growth 48.73%
Profitability
14 /100
Weak Gross margin 8.29%
Net margin 3.80%
Op. margin 5.33%
Quality
25 /100
Poor ROIC 3.80%
ROE 3.34%
ROA 2.91%
Debt
90 /100
Low Debt/Equity 0.00x
Current ratio 1.13x
Net debt/EBITDA -0.07x
Stability
45 /100
Moderate Beta 0.70x
Rev. volatility 46.30%
EPS volatility 65.85%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RAFA
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Sergey Brusnitsin
Employees
700
Headquarters
Sandy